Real-life experiences: GLP-1s in action As you read these real life stories, remember that GLP-1 use is not currently FDA approved for people with type 1 diabetes, and results may vary
First, there is supporting evidence for the safety of GLP-1RAs across the board of cognitive and mental disorders, as we retrieved very few studies 44,159,181,182,193,205 suggesting worse neuropsychiatric outcomes associated with these medications (Tables 16, Fig
However, these expert consensusbased research criteria were quite restrictive and were found to be less useful for clinical purposes
Acta 1649 , 5157 (2003)
Coverage for chronic weight management without diabetes is plan-specific and often requires prior authorization with documented BMI, weight-related comorbidities, and sometimes prior treatment failures
Consider starting with single-peptide protocols and adding TB-500 if response proves inadequate after 4-6 weeks